Replimune Group (REPL) Stock Price, Quote, News & History | Benzinga

Replimune Group Inc (REPL) Stock Price, Quote, News & History

REPLNASDAQ

Trade with Public

Trade with Public

$5.22

0.295.88%

At close: May 15, 5:00 PM EST

$5.12

-0.1-1.92%

After Hours: 7:55 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.90

Close

$5.22

Volume / Avg.

5.88M / 5.72M

Day Range

$4.75 - $5.41

52 Wk Range

1.50 - 13.24

Market Cap

$401.63M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

50.44%

Days to Cover

2.64

Recent Replimune Group Inc News

Micron Rallied 90% In A Month — These 10 Small‑Cap Stocks Blew Past It

Micron's 90% one-month rally has been the loudest story of the AI memory cycle. Ten Russell 2000 stocks just blew past it, with one up 381%.

Piero Cingari

What's Going On With Replimune Stock On Tuesday?

FDA Chief Marty Makary defends decisions amid backlash over drug rejections, internal turmoil and criticism from biotech firms and lawmakers.

Vandana Singh

FDA Rejection Sparks Questions On Replimune Drug Approval Path

Replimune gets FDA CRL for RP1 melanoma therapy, disputes review process as analysts cut ratings and price targets sharply.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-277.91M

Investing Cash Flow (TTM)

216.64M

Financing Cash Flow (TTM)

10.49M

Free Cash Flow (TTM)

-283.27M

Capital Expenditure (TTM)

-5.35M

Net Change in Cash (TTM)

-50.79M

Analyst Trends and Forecast

2

Feb

3

2

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$213.47M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.93

Earnings Yield % (TTM)

-69.92%

Earnings Yield % (FWD)

-55.08%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.55

Company Debt

Total Debt

$47.63M

LT Debt

$47.63M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$701.00K

Total Cash

$122.95M

Debt to Equity

0.36

Issuance of Debt (TTM)

-$701.00K

Repayment of Debt (TTM)

-$701.00K

Key Statistics

Open

$4.90

Close

$5.22

Volume / Avg.

5.88M / 5.72M

Day Range

$4.75 - $5.41

52 Wk Range

1.50 - 13.24

Market Cap

$401.63M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

50.44%

Days to Cover

2.64

About

Sector

Health Care

Industry

Biotechnology

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Replimune Group (REPL) stock?

A

You can purchase shares of Replimune Group (NASDAQ:REPL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Replimune Group (REPL) competitors?

A

There are no as such competitors for Replimune Group.

Q

What is the forecast, or price target, for Replimune Group (REPL) stock?

A

Replimune Group has a consensus price target of $13.88.

Q

What is the current price for Replimune Group (REPL)?

A

The stock price for Replimune Group (NASDAQ: REPL) is $5.12 last updated May 15, 2026 at 7:55 PM EDT.

Q

Does Replimune Group (REPL) pay a dividend?

A

There are no upcoming dividends for Replimune Group.

Q

When is Replimune Group (NASDAQ:REPL) reporting earnings?

A

Replimune Group does not have any upcoming earnings scheduled.

Q

Is Replimune Group (REPL) going to split?

A

There is no upcoming split for Replimune Group.

Q

What sector and industry does Replimune Group (REPL) operate in?

A

Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.